According to the Zhitong Finance App, Chia Tai Biotech (03839.HK) announced its 2026 interim results, with revenue of about US$211 million, a year-on-year decrease of 34.62%; profit attributable to the company's shareholders was US$9.423 million, a year-on-year decrease of 44.72%; profit per share was 3.7 cents.

According to the Zhitong Finance App, Chia Tai Biotech (03839.HK) announced its 2026 interim results, with revenue of about US$211 million, a year-on-year decrease of 34.62%; profit attributable to the company's shareholders was US$9.423 million, a year-on-year decrease of 44.72%; profit per share was 3.7 cents.